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Abstract
This study compared the incidence of lung cancer among Puerto Ricans (PRs) with that of Whites, 
Blacks, and Hispanics in the United States. We computed age-standardized rates of lung cancer 
during 1992–2010 and percentages of change over time. Standardized rate ratios (SRR) were 
estimated to assess racial/ethnic and gender differences. All men groups showed a significant 
decline in lung cancer over time but PRs observed the smallest change (−1.2%). For both men and 
women, PRs had lower incidence rates compared to other racial/ethnic groups (SRR<1; P<0.05). 
Among all groups, men reported higher incidence rates than women but PRs showed the largest 
gender disparity (SRR=2.29). This study showed that although PRs exhibited lower incidence 
rates of lung cancer, this subgroup of Hispanics faced a high burden of lung cancer, principally 
because PR men had the smallest decline over time and the largest gender difference among all 
groups.
Keywords
Puerto Ricans; lung cancer; cancer incidence; cancer disparities
Corresponding author: William A. Calo, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, 
Department of Health Policy and Management, 1102-F McGavran-Greenberg Bldg, CB 7411, Chapel Hill, NC 27599-7411, Phone: 
(919) 843-5507 / wacalo@live.unc.edu. 
HHS Public Access
Author manuscript
J Immigr Minor Health. Author manuscript; available in PMC 2015 July 01.
Published in final edited form as:
J Immigr Minor Health. 2015 June ; 17(3): 971–975. doi:10.1007/s10903-014-0153-1.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Introduction
Lung cancer rates vary considerably among countries and among racial/ethnic populations 
within countries (1). In the U.S., lung cancer is the second most common diagnosed cancer 
in both men and women, and it also ranks first in cancer deaths (2). During the past several 
decades, lung cancer rates have declined in the U.S., largely explained by a decline in the 
tobacco epidemic (3). Nonetheless, this reduction is not similar among both genders and 
racial/ethnic groups, resulting in cancer disparities. For instance, higher incidence rates are 
observed among non-Hispanic Black (NHB) men than in other populations, including non-
Hispanic White (NHW) and U.S. Hispanic (USH) groups (3, 4). Despite such disparities, 
lung cancer is among the top four sites of cancer incidence among the three above 
mentioned racial/ethnic groups (5).
In Puerto Rico, a Commonwealth territory of the U.S., lung cancer is the third most common 
diagnosed cancer among men and the fifth among women (6.9% and 4.3% of all new 
cancers, respectively) (6). Lung cancer also ranks as the second deadliest cancer among 
Puerto Rican (PR) men and the third among women (13.1% and 9.7% of all cancer deaths, 
respectively) (6). Although there is extensive literature reporting lung cancer incidence 
trends for NHWs, NHBs, and USHs (2–5); PRs have not been included in those analyses. As 
of today, there is no study comparing recent lung cancer incidence data between PRs and 
other racial/ethnic groups in the U.S. Such a comparison is not only necessary to understand 
lung cancer differences across the increasingly diverse U.S. population but to inform public 
health interventions aimed at addressing existing cancer disparities in the U.S. mainland and 
territories, which is a vital element of the Nation’s health agenda (7). Given the limited body 
of research on the burden of lung cancer in Puerto Rico, this study is aimed at assessing age-
standardized incidence rates of lung cancer among PRs and compared these to that of 
NHWs, NHBs, and USHs for the period 1992–2010.
Methods
Data sources
Lung cancer data for PRs were obtained from the Puerto Rico Central Cancer Registry 
(PRCCR) and data for NHWs, NHBs, and USHs came from the Surveillance, 
Epidemiology, and End Results (SEER) program (SEER 13 database). The PRCCR, part of 
the Centers for Disease Control and Prevention’s National Program of Cancer Registries, 
uses the coding standards of the SEER program and of the North American Association of 
Central Cancer Registries, which makes the PRCCR data fully comparable to the SEER data 
(6). The criteria specified in the third edition of the International Classification of Diseases 
for Oncology (ICD-O-3) were used to select lung cancer cases from 2001 to 2010 (8). Cases 
from 1992 to 2000 were originally reported using ICD-O-2 and later converted to ICD-O-3. 
USH were identified by the SEER program using a combination of medical record review 
and matching surnames against a list of Hispanic surnames (9). Our study does not account 
for group differences within the USH population. Data were analyzed for adults ≥40 years of 
age. This study was approved by the Institutional Review Board of the University of Puerto 
Rico Medical Sciences Campus.
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Statistical analyses
For each racial/ethnic group, we applied the direct method to calculate age-standardized 
rates (ASR) per 100,000 individuals using the world standard population as reference. To 
assess the trends of lung cancer incidence, we calculated the annual ASR from 1992 to 2010 
as follows:
where j represents a given age group, i represents a given racial/ethnic group, k represents a 
given year, w is the proportion of people in the world population to be evaluated, d is the 
number of new cases, and n is the total population (10). We also calculated the percentage of 
change in the ASR for the long-term of 1992–2010 and the latest 5-year period of 2006–
2010. The significance of the percentage of change was determined by 95% confidence 
intervals (CI).
To assess racial/ethnic group differences, we grouped the ASR values for the 2006–2010 
period as follows:
Then, the ratio of two ASR (ASR groupi/ASR groupj) between two groups (i and j) was 
estimated with 95% CI to compute differences in lung cancer incidence of PRs versus 
NHWs, NHBs, and USHs, respectively, and between men and women from the same racial/
ethnic group. This ratio is referred to as the standardized rate ratio (SRR) (11). Following 
the example of others (3), we restricted the latter analysis for the short-term of 2006–2010 in 
order to provide the most recent and accurate estimates of SRRs. All analyses were stratified 
by sex and performed using Stata/SE version 12 (Stata Corp., LP, College Station, TX). A 
detailed description of our analysis plan is presented elsewhere (12, 13).
Results
Trends of age-standardized rates (1992–2010)
Figure 1 shows different time-trends of lung cancer incidence between racial/ethnic groups; 
both PR men and women had the lowest rates from 1992 to 2010. All men groups showed a 
statistically significant (P<0.05) decline over time but PRs observed the smallest percentage 
of change (–1.2%). Among women, a statistically significant decline was only observed for 
PRs (–0.4%; P<0.05). In contrast, both NHW and NHB women groups observed statistically 
significant increase over time. On the other hand, all racial/ethnic groups observed a 
statistically significant decline in lung cancer incidence from 2006 to 2010 (data not shown); 
among men, the largest decline was observed in NHBs (−3.0%) and among women, in PRs 
(−0.4%).
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Standardized rate ratios (2006–2010)
Both PR men and women had the lowest age-standardized incidence when compared to their 
NHW, NHB, and USH counterparts (Table 1). Among all racial/ethnic groups, men reported 
higher incidence rates than women (P<0.05), and the PR group showed the largest gender 
difference in lung cancer among groups (SRR= 2.29; 95% CI= 2.13–2.46). For both men 
and women, PRs had lower incidences of lung cancer than the other three groups (P<0.05). 
Incidence rates were four times lower in PR men than NHB men (SRR= 0.26; 95% CI= 
0.25–0.27) and five times lower in PR women than NHW (SRR= 0.20; 95% CI= 0.19–0.21) 
and NHB women (SRR= 0.19; 95% CI= 0.18–0.20).
Discussion
This study indicates that lung cancer incidence rates among PRs were lower compared to 
those of NHWs, NHBs, and USHs. These results may be explained by differences in 
smoking prevalence across racial/ethnic groups. The unequivocal role of tobacco use in 
causing lung cancer is one of the most thoroughly documented causal relationships in 
biomedical research (14). Historically, PRs have reported a much lower prevalence of 
cigarette smoking than NHW, NHB, and USH groups (15, 16), potentially explaining why 
PRs showed a lower incidence of lung cancer for both men and women as compared to the 
other groups.
The declining trends of lung cancer occurrence observed in all men groups could be 
explained by the descending patterns of smoking prevalence among these populations. 
Evidence shows that lung cancer trends follow the smoking patterns occurring 
approximately three decades earlier in a population (17, 18). Smoking prevalence among 
U.S. adult men has decreased from 51.9% in 1965 to 21.5% in 2010 (19). Declining trends 
in smoking have also been reported specifically for NHW, NHB, and USH men (16). 
Historical data on cigarette use among PR adults also shows declining trends of smoking for 
this group (15). In opposition to the declining trends observed in men, only PR women 
showed a decreased trend in lung cancer. An explanation for these findings might be that 
women smoking patterns have been reported to be lagged by several decades behind those 
of men (17, 18). All these different patterns of smoking prevalence and lung cancer trends 
between men and women might explain the large gender disparities observed across all 
racial/ethnic groups in this study.
Genetic polymorphisms (e.g., GSTM1 null) resulting in variation in metabolism of tobacco 
carcinogens may also influence lung cancer risk. Although we have found no published 
research on genotype-associated susceptibility of lung cancer among PRs, Xie et al. (20) 
conducted a case-control study to investigate the role of GSTM1 in oral cancer risk in this 
population. The authors found that risks increased with increasing cigarette use (P for trend 
<0.0001) among PR with the GSTM1-present genotype, up to 9 times higher risk (OR= 9.5; 
95% CI= 3.0–30) among the heaviest smokers.
The strength of this study arises from the quality of the data analyzed. Ninety five percent of 
all cancer cases diagnosed in Puerto Rico are appropriately reported to the PRCCR, which is 
a rate comparable to the U.S. (6). However, some limitations should be acknowledged. First, 
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we were unable to compare lung cancer data between mainland and island PRs because the 
SEER program classifies all Hispanic individuals who live in the continental U.S. under the 
broad category of Hispanics. Second, we were unable to analyze data on lung cancer risk 
factors because neither the PRCCR nor the SEER program collects such information. It will 
be important as others cite and use our data to keep in mind that when statewide tobacco 
control interventions are introduced, larger reductions in lung cancer incidence are expected 
among populations with higher smoking prevalence because they may experience larger 
changes in smoking cessation over time.
In conclusion, despite the lower rates of lung cancer observed among PRs as compared to 
other racial/ethnic groups in the U.S., lung cancer continues to be a public health priority in 
Puerto Rico; principally because PR men had the smallest decline over time and the largest 
gender difference.
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Figure 1. 
Trends for lung cancer incidence by race/ethnic group, 1992–2010.
Calo et al. Page 7
J Immigr Minor Health. Author manuscript; available in PMC 2015 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Calo et al. Page 8
Ta
bl
e 
1
A
ge
-s
ta
nd
ar
di
ze
d 
in
ci
de
nc
e 
ra
te
s (
pe
r 1
00
,00
0) 
an
d s
tan
da
rdi
ze
d r
ate
 ra
tio
s f
or 
lun
g c
an
ce
r, 2
00
6–
20
10
.
A
ge
-s
ta
nd
ar
di
ze
d 
in
ci
de
nc
e 
(p
er
 10
0,0
00
)
SR
R
 (9
5%
 C
I)a
PR
N
H
W
N
H
B
U
SH
PR
 v
s. 
N
H
W
b
PR
 v
s. 
N
H
Bb
PR
 v
s. 
U
SH
b
M
en
52
.4
15
0.
9
19
7.
3
86
.4
0.
35
 (0
.33
–0
.36
)
0.
26
 (0
.25
–0
.27
)
0.
63
 (0
.60
–0
.67
)
W
om
en
22
.3
11
2.
8
11
2.
0
53
.2
0.
20
 (0
.19
–0
.21
)
0.
19
 (0
.18
–0
.20
)
0.
43
 (0
.40
–0
.46
)
SR
R 
(95
% 
CI
)c
2.
29
 (2
.13
–2
.46
)
1.
29
 (1
.27
–1
.31
)
1.
70
 (1
.64
–1
.76
)
1.
56
 (1
.49
–1
.64
)
Le
ge
nd
: P
R 
= 
Pu
er
to
 R
ic
an
s; 
N
H
W
 =
 n
on
-H
isp
an
ic
 w
hi
te
s; 
N
H
B 
= 
no
n-
H
isp
an
ic
 b
la
ck
s; 
U
SH
 =
 U
.S
. H
isp
an
ic
s.
a
SR
R 
= 
sta
nd
ar
di
ze
d 
ra
te
 ra
tio
s; 
95
%
 C
I =
 9
5%
 co
nf
id
en
ce
 in
te
rv
al
s.
b R
ef
er
en
ce
 g
ro
up
.
c S
RR
 =
 st
an
da
rd
iz
ed
 ra
te
 ra
tio
s; 
95
%
 C
I =
 9
5%
 co
nf
id
en
ce
 in
te
rv
al
s; 
w
om
en
 as
 th
e r
ef
er
en
ce
 g
ro
up
.
J Immigr Minor Health. Author manuscript; available in PMC 2015 July 01.
